Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Repro Med Sys Inc (REPR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 63,707
  • Shares Outstanding, K 38,610
  • Annual Sales, $ 12,290 K
  • Annual Income, $ -530 K
  • 36-Month Beta -0.61
  • Price/Sales 4.87
  • Price/Cash Flow N/A
  • Price/Book 7.55
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.02
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.4100 +13.48%
on 10/25/18
1.7750 -9.86%
on 11/08/18
+0.0300 (+1.91%)
since 10/12/18
3-Month
1.1800 +35.59%
on 08/29/18
1.8000 -11.11%
on 10/04/18
+0.2900 (+22.14%)
since 08/13/18
52-Week
0.6200 +158.06%
on 11/14/17
1.8000 -11.11%
on 10/04/18
+0.9399 (+142.39%)
since 11/13/17

Most Recent Stories

More News
RMS Medical Products to Present at Upcoming Investor Conferences

CHESTER, NY / ACCESSWIRE / November 9, 2018 / Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) today announced that Dan Goldberger, Chairman and interim Chief Executive Officer, will be presenting...

REPR : 1.6000 (-3.03%)
RMS Medical Products Announces Second Straight Record Quarterly Net Sales and Net Income

Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) today announced financial results for the third quarter ended September 30, 2018.

REPR : 1.6000 (-3.03%)
RMS Medical Products to Report Third Quarter 2018 Results October 23, 2018

CHESTER, NY / ACCESSWIRE / October 16, 2018 / Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) today announced that it will release its financial results for the third quarter ended September...

REPR : 1.6000 (-3.03%)
UPDATE: OTC Markets Group Announces Agenda for OTCQX Virtual Investor Conference on October 4

NEW YORK, NY / ACCESSWIRE / September 26, 2018 / (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the agenda for its upcoming OTCQX® Virtual Investor...

SMDM : 0.4000 (unch)
FRHC : 8.5900 (-0.12%)
LXRP : 1.3000 (-5.11%)
OTCM : 32.0000 (+0.31%)
TOMZ : 0.0849 (+8.85%)
REPR : 1.6000 (-3.03%)
MACE : 0.3500 (-5.28%)
SOTK : 2.7800 (-4.14%)
GRWG : 3.3700 (-2.88%)
ZDPY : 0.4700 (-2.08%)
STXS : 1.3700 (+5.38%)
AMAZ : 0.2096 (-2.51%)
MNTR : 0.6000 (-3.23%)
GTBIF : 12.0610 (+1.35%)
DYAI : 1.8800 (-1.05%)
RMS Medical Products Announces Appointment of President and Chief Commercial Officer Donald Pettigrew

CHESTER, N.Y. , Sept. 4, 2018 /PRNewswire/ -- Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) today announced that Donald B. Pettigrew has been appointed to the position of President...

REPR : 1.6000 (-3.03%)
RMS Medical Products Announces Appointment of President and Chief Commercial Officer Donald Pettigrew

Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) today announced that Donald B. Pettigrew has been appointed to the position of President and Chief Commercial Officer.

REPR : 1.6000 (-3.03%)
RMS Medical Products to Present at the 7th Annual Liolis Gateway Conference

Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) today announced that Chairman and Interim President and Chief Executive Officer Dan Goldberger will be presenting at the 7th annual Liolis...

REPR : 1.6000 (-3.03%)
RMS Medical Products Announces Record Quarterly Sales and Net Income

Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) today announced financial results for the second quarter ended June 30, 2018.

REPR : 1.6000 (-3.03%)
Liolios 7th Annual Gateway Conference to Showcase 100 Leading Companies at the Four Seasons San Francisco September 5-6, 2018

Corporate Leaders from a Range of Industries to Present to 400+ Institutional Investors and Analysts

BRT : 12.07 (+2.72%)
BBSI : 72.95 (-4.78%)
DSKE : 5.26 (+2.73%)
TGO.TO : 9.72 (-1.12%)
AHT : 5.16 (+2.18%)
VERI : 6.78 (-1.45%)
CDXC : 3.41 (-1.16%)
DUOT : 0.5300 (unch)
IMI : 0.94 (unch)
INUV : 1.27 (+8.55%)
JSDA : 0.3050 (unch)
PRTS : 1.15 (+0.88%)
BMRA : 2.90 (+3.57%)
ESCA : 12.15 (+1.67%)
AEYE : 5.66 (-0.18%)
STKS : 2.97 (-4.19%)
HCI : 53.20 (-2.80%)
AUTO : 2.27 (+5.09%)
PCOM : 12.14 (-2.18%)
INVE : 6.13 (-5.69%)
IMXI : 12.50 (unch)
MVIS : 0.97 (unch)
GMRE : 9.40 (+0.32%)
VTSI : 4.66 (-2.92%)
NTWK : 7.89 (+4.23%)
NBEV : 3.26 (-5.23%)
CLAR : 11.59 (+1.22%)
RSSS : 2.4000 (unch)
TPB : 34.24 (-3.74%)
BLDP : 3.06 (+3.03%)
SBKK : 12.9500 (unch)
TTGT : 15.94 (-3.51%)
ZIXI : 6.37 (-3.92%)
DZSI : 14.34 (+3.69%)
HEAR : 15.01 (-1.77%)
OOMA : 14.76 (-2.57%)
REPR : 1.6000 (-3.03%)
GAIA : 11.85 (-0.42%)
SHSP : 13.27 (+1.76%)
SRT : 6.17 (+1.65%)
GSB : 4.60 (+3.60%)
DMRC : 20.51 (-1.06%)
EVLV : 1.15 (unch)
AJX.TO : 0.85 (unch)
OXBR : 1.06 (+0.95%)
COWN : 15.42 (-1.47%)
SNMX : 1.49 (-0.67%)
EVOA : 0.1500 (unch)
IDSY : 5.84 (-4.34%)
PFNX : 4.87 (-3.56%)
SELF : 4.02 (-0.25%)
MJCO : 7.76 (+4.16%)
UAVS : 0.82 (+1.23%)
CODI : 15.39 (-1.85%)
LXXGF : 0.5836 (-2.57%)
SSTI : 37.18 (+3.11%)
JAKK : 2.42 (-5.47%)
CTG : 4.32 (-1.82%)
CLFD : 12.09 (-8.13%)
AMRK : 12.61 (-1.18%)
HCAC : 10.22 (+0.49%)
PFSW : 6.70 (+0.30%)
RMS Medical Products Victory as U.S. Federal Circuit Court of Appeals Invalidates EMED Technologies Corp.'s Patent, Nullifying Infringement Claim

CHESTER, NY / ACCESSWIRE / April 9, 2018 / Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR; the "Company") is pleased to announce that the United States Court of Appeals for the Federal Circuit...

REPR : 1.6000 (-3.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade REPR with:

Key Turning Points

2nd Resistance Point 1.6800
1st Resistance Point 1.6400
Last Price 1.6000
1st Support Level 1.5700
2nd Support Level 1.5400

See More

52-Week High 1.8000
Last Price 1.6000
Fibonacci 61.8% 1.3492
Fibonacci 50% 1.2100
Fibonacci 38.2% 1.0708
52-Week Low 0.6200

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar